JP2009528138A - 生理学的輸出液収集部位からの医療用薬剤の回収のための方法およびデバイス - Google Patents
生理学的輸出液収集部位からの医療用薬剤の回収のための方法およびデバイス Download PDFInfo
- Publication number
- JP2009528138A JP2009528138A JP2008557430A JP2008557430A JP2009528138A JP 2009528138 A JP2009528138 A JP 2009528138A JP 2008557430 A JP2008557430 A JP 2008557430A JP 2008557430 A JP2008557430 A JP 2008557430A JP 2009528138 A JP2009528138 A JP 2009528138A
- Authority
- JP
- Japan
- Prior art keywords
- sensor
- site
- suction
- drug
- collection site
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012530 fluid Substances 0.000 title claims abstract description 195
- 239000003814 drug Substances 0.000 title claims abstract description 167
- 229940079593 drug Drugs 0.000 title claims abstract description 157
- 238000000034 method Methods 0.000 title claims abstract description 105
- 238000011084 recovery Methods 0.000 title description 7
- 239000000032 diagnostic agent Substances 0.000 claims abstract description 10
- 229940039227 diagnostic agent Drugs 0.000 claims abstract description 10
- 230000007246 mechanism Effects 0.000 claims description 73
- 239000007788 liquid Substances 0.000 claims description 69
- 239000000835 fiber Substances 0.000 claims description 45
- 210000003748 coronary sinus Anatomy 0.000 claims description 41
- 239000002872 contrast media Substances 0.000 claims description 39
- 238000001514 detection method Methods 0.000 claims description 34
- 230000003287 optical effect Effects 0.000 claims description 18
- 210000005245 right atrium Anatomy 0.000 claims description 13
- 230000005540 biological transmission Effects 0.000 claims description 11
- 210000003462 vein Anatomy 0.000 claims description 10
- 210000002216 heart Anatomy 0.000 claims description 8
- 230000002526 effect on cardiovascular system Effects 0.000 claims description 7
- 230000002792 vascular Effects 0.000 claims description 6
- 230000009977 dual effect Effects 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 2
- 238000012544 monitoring process Methods 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 abstract description 47
- 229940124597 therapeutic agent Drugs 0.000 abstract description 10
- 230000001225 therapeutic effect Effects 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 description 38
- 239000008280 blood Substances 0.000 description 38
- 230000027455 binding Effects 0.000 description 36
- 239000013307 optical fiber Substances 0.000 description 32
- 238000001802 infusion Methods 0.000 description 27
- 239000000126 substance Substances 0.000 description 25
- 238000002347 injection Methods 0.000 description 18
- 239000007924 injection Substances 0.000 description 18
- 239000000463 material Substances 0.000 description 18
- 150000001875 compounds Chemical class 0.000 description 15
- 150000003384 small molecules Chemical group 0.000 description 13
- 239000012491 analyte Substances 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 239000003446 ligand Substances 0.000 description 11
- 230000008859 change Effects 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 210000000056 organ Anatomy 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- 238000011144 upstream manufacturing Methods 0.000 description 9
- 230000000747 cardiac effect Effects 0.000 description 8
- 239000000975 dye Substances 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 7
- 230000001746 atrial effect Effects 0.000 description 7
- 230000033001 locomotion Effects 0.000 description 7
- 238000010183 spectrum analysis Methods 0.000 description 7
- 238000004891 communication Methods 0.000 description 6
- 238000003384 imaging method Methods 0.000 description 6
- 230000003993 interaction Effects 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 238000007789 sealing Methods 0.000 description 6
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 5
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 230000001839 systemic circulation Effects 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 210000003484 anatomy Anatomy 0.000 description 4
- 238000004873 anchoring Methods 0.000 description 4
- 238000002583 angiography Methods 0.000 description 4
- 210000004351 coronary vessel Anatomy 0.000 description 4
- 229940127089 cytotoxic agent Drugs 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 230000000544 hyperemic effect Effects 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 238000010188 recombinant method Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 210000005166 vasculature Anatomy 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- 206010020565 Hyperaemia Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000002246 antineoplastic agent Substances 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical group 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- 230000024883 vasodilation Effects 0.000 description 3
- 108091023037 Aptamer Proteins 0.000 description 2
- 208000009079 Bronchial Spasm Diseases 0.000 description 2
- 208000014181 Bronchial disease Diseases 0.000 description 2
- 206010006482 Bronchospasm Diseases 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 206010020850 Hyperthyroidism Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 230000010100 anticoagulation Effects 0.000 description 2
- 230000001640 apoptogenic effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 239000002254 cytotoxic agent Substances 0.000 description 2
- 231100000599 cytotoxic agent Toxicity 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000002592 echocardiography Methods 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- 238000002594 fluoroscopy Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000028709 inflammatory response Effects 0.000 description 2
- 238000013152 interventional procedure Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 230000000926 neurological effect Effects 0.000 description 2
- 230000001151 other effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000008742 procoagulation Effects 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 230000011514 reflex Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000002550 vasoactive agent Substances 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 241000282579 Pan Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003872 anastomosis Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 210000002565 arteriole Anatomy 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000002586 coronary angiography Methods 0.000 description 1
- 238000007887 coronary angioplasty Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000002716 delivery method Methods 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000026058 directional locomotion Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000012953 feeding on blood of other organism Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 238000002615 hemofiltration Methods 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000005305 interferometry Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- XQZXYNRDCRIARQ-LURJTMIESA-N iopamidol Chemical compound C[C@H](O)C(=O)NC1=C(I)C(C(=O)NC(CO)CO)=C(I)C(C(=O)NC(CO)CO)=C1I XQZXYNRDCRIARQ-LURJTMIESA-N 0.000 description 1
- 229960004647 iopamidol Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000005246 left atrium Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004137 mechanical activation Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000002357 osmotic agent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000001147 pulmonary artery Anatomy 0.000 description 1
- 210000003492 pulmonary vein Anatomy 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 210000002254 renal artery Anatomy 0.000 description 1
- 210000002796 renal vein Anatomy 0.000 description 1
- 230000000250 revascularization Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000003229 sclerosing agent Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 210000000264 venule Anatomy 0.000 description 1
- 210000002385 vertebral artery Anatomy 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
- A61M1/74—Suction control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/64—Containers with integrated suction means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/80—Suction pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/84—Drainage tubes; Aspiration tips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0082—Catheter tip comprising a tool
- A61M2025/0096—Catheter tip comprising a tool being laterally outward extensions or tools, e.g. hooks or fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1047—Balloon catheters with special features or adapted for special applications having centering means, e.g. balloons having an appropriate shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1011—Multiple balloon catheters
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- External Artificial Organs (AREA)
- Surgical Instruments (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77881606P | 2006-03-02 | 2006-03-02 | |
| US80729706P | 2006-07-13 | 2006-07-13 | |
| PCT/US2007/005537 WO2007103279A2 (en) | 2006-03-02 | 2007-03-02 | Methods and devices for retrieval of a medical agent from a physiological efferent fluid collection site |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009528138A true JP2009528138A (ja) | 2009-08-06 |
| JP2009528138A5 JP2009528138A5 (enExample) | 2010-04-15 |
Family
ID=38475452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008557430A Pending JP2009528138A (ja) | 2006-03-02 | 2007-03-02 | 生理学的輸出液収集部位からの医療用薬剤の回収のための方法およびデバイス |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20090187131A1 (enExample) |
| EP (1) | EP1996255B1 (enExample) |
| JP (1) | JP2009528138A (enExample) |
| WO (1) | WO2007103279A2 (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010042099A (ja) * | 2008-08-11 | 2010-02-25 | Olympus Corp | 脂肪吸引装置 |
| JP2011516204A (ja) * | 2008-04-10 | 2011-05-26 | ヘンリー フォード ヘルス システム | 心臓静脈系内に構造部材を形成するための方法、装置およびキット |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008157256A1 (en) | 2007-06-13 | 2008-12-24 | Catharos Medical Systems, Inc. | Methods and devices for removal of a medical agent from a physiological efferent fluid collection site |
| WO2009067711A2 (en) * | 2007-11-21 | 2009-05-28 | T.J. Smith & Nephew, Limited | Suction device and dressing |
| US8100860B2 (en) * | 2007-12-06 | 2012-01-24 | Abbott Laboratories | Device and method for treating vulnerable plaque |
| US20110263976A1 (en) * | 2008-07-18 | 2011-10-27 | Hassan Ali H | Methods and Devices for Endovascular Introduction of an Agent |
| JP5336595B2 (ja) * | 2008-08-08 | 2013-11-06 | ケーシーアイ ライセンシング インコーポレイテッド | リザーバ制御付減圧治療システム |
| US9050400B2 (en) * | 2008-08-12 | 2015-06-09 | Osprey Medical, Inc. | Remote sensing catheter system and methods |
| CN102458235A (zh) * | 2009-04-29 | 2012-05-16 | 药物影像股份有限公司 | 用于管内流体光学传感的自穿透皮肤的光学传感器 |
| US9295816B2 (en) * | 2009-12-09 | 2016-03-29 | Osprey Medical, Inc. | Catheter with distal and proximal ports |
| DE102011008051A1 (de) * | 2011-01-07 | 2012-07-12 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Bereich Universitätsmedizin | Absaugvorrichtung |
| US8870769B2 (en) | 2011-05-23 | 2014-10-28 | Covidien Lp | Inter dialytic monitoring device |
| US9211372B2 (en) | 2011-08-11 | 2015-12-15 | Osprey Medical, Inc. | Systems and methods for limb treatment |
| US8622957B2 (en) * | 2011-08-23 | 2014-01-07 | Boston Scientific Scimed, Inc. | Adjustable variable stiffness transluminal device |
| US9492071B2 (en) | 2012-04-05 | 2016-11-15 | Stryker Corporation | In-joint sensor for a surgical fluid management pump system |
| US10041960B2 (en) * | 2013-05-10 | 2018-08-07 | University Of Utah Research Foundation | Devices, systems, and methods for measuring blood loss |
| US10690684B2 (en) | 2013-05-10 | 2020-06-23 | Majelco Medical, Inc. | Apparatus and system for measuring volume of blood loss |
| US10285596B2 (en) | 2016-04-11 | 2019-05-14 | Majelco Medical, Inc. | Apparatus and system for measuring volume of blood loss |
| US20170106199A1 (en) | 2015-10-16 | 2017-04-20 | Brady L. WOOLFORD | Integrated pump control for dynamic control of plasma field |
| CN113395931A (zh) * | 2018-12-12 | 2021-09-14 | 爱德华兹生命科学公司 | 集成压力感测的心脏植入装置 |
| JP7061585B2 (ja) * | 2019-03-20 | 2022-04-28 | 富士フイルム株式会社 | 内視鏡 |
| US20230083848A1 (en) * | 2021-09-16 | 2023-03-16 | Ali F. ABOUFARES | Renal vein aspiration system and method |
| US12220139B2 (en) | 2022-03-20 | 2025-02-11 | Von Vascular, Inc. | System, devices and methods for removing obstructions in body lumens |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1986003832A1 (en) * | 1984-12-17 | 1986-07-03 | Bellhouse Medical Products Limited | Fibre optic sensor |
| JP2004514466A (ja) * | 2000-05-31 | 2004-05-20 | カーベロス・プロクシマル・ソルーションズ・インコーポレーテッド | 脈管治療法用の塞栓症の保護装置 |
| US20040254523A1 (en) * | 2003-03-18 | 2004-12-16 | Fitzgerald Peter J. | Methods and devices for retrieval of a medical agent from a physiological efferent fluid collection site |
| JP2005503183A (ja) * | 2001-01-23 | 2005-02-03 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 心臓および身体の他の部分の血管から物質を除去して腎臓または他の器官の障害または不全をなくすかできるだけ少なくする方法および装置 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH464574A (de) * | 1966-10-21 | 1968-10-31 | Ciba Geigy | Vorrichtung zur kontinuierlichen Ausführung von Messungen |
| US4103685A (en) * | 1976-01-05 | 1978-08-01 | Lupien Paul J | Method and apparatus for extravascular treatment of blood |
| US4652255A (en) * | 1983-10-28 | 1987-03-24 | Miguel Martinez | Irrigating and aspirating handpiece for use in ophthalmic surgery |
| US4792689A (en) * | 1985-11-12 | 1988-12-20 | The United States Of America As Represented By The Department Of Health And Human Services | Method for obtaining a ratio measurement for correcting common path variations in intensity in fiber optic sensors |
| JP2511092B2 (ja) * | 1988-01-30 | 1996-06-26 | 日産自動車株式会社 | 流体用センサ |
| US5113358A (en) * | 1990-03-28 | 1992-05-12 | Barber-Colman Company | Web caliper measuring system |
| WO1993024082A1 (en) * | 1992-06-03 | 1993-12-09 | Allergan, Inc. | Tubing management system |
| US5540659A (en) * | 1993-07-15 | 1996-07-30 | Teirstein; Paul S. | Irradiation catheter and method of use |
| US7799004B2 (en) * | 2001-03-05 | 2010-09-21 | Kci Licensing, Inc. | Negative pressure wound treatment apparatus and infection identification system and method |
| GB2350794A (en) * | 1999-04-20 | 2000-12-13 | Nagy Adly Habib | Implantable pump |
| FR2832233B1 (fr) | 2001-11-13 | 2004-01-02 | France Telecom | Reconfiguration de composants programmables dans un appareil electronique |
| WO2003045303A2 (en) * | 2001-11-21 | 2003-06-05 | E-Z-Em, Inc. | Device, system, kit or method for collecting effluent from an individual |
| US20050004476A1 (en) * | 2003-05-28 | 2005-01-06 | Saeed Payvar | Method and apparatus for detecting ischemia |
| EP1662987B1 (en) * | 2003-09-11 | 2011-11-09 | Theranos, Inc. | Medical device for analyte monitoring and drug delivery |
| US7235098B2 (en) * | 2003-09-18 | 2007-06-26 | Advanced Bio Prosthetic Surfaces, Ltd. | Medical devices having MEMs functionality and methods of making same |
-
2007
- 2007-03-02 EP EP07752251.4A patent/EP1996255B1/en not_active Not-in-force
- 2007-03-02 JP JP2008557430A patent/JP2009528138A/ja active Pending
- 2007-03-02 WO PCT/US2007/005537 patent/WO2007103279A2/en not_active Ceased
- 2007-03-02 US US12/281,141 patent/US20090187131A1/en not_active Abandoned
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1986003832A1 (en) * | 1984-12-17 | 1986-07-03 | Bellhouse Medical Products Limited | Fibre optic sensor |
| JP2004514466A (ja) * | 2000-05-31 | 2004-05-20 | カーベロス・プロクシマル・ソルーションズ・インコーポレーテッド | 脈管治療法用の塞栓症の保護装置 |
| JP2005503183A (ja) * | 2001-01-23 | 2005-02-03 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 心臓および身体の他の部分の血管から物質を除去して腎臓または他の器官の障害または不全をなくすかできるだけ少なくする方法および装置 |
| US20040254523A1 (en) * | 2003-03-18 | 2004-12-16 | Fitzgerald Peter J. | Methods and devices for retrieval of a medical agent from a physiological efferent fluid collection site |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011516204A (ja) * | 2008-04-10 | 2011-05-26 | ヘンリー フォード ヘルス システム | 心臓静脈系内に構造部材を形成するための方法、装置およびキット |
| JP2010042099A (ja) * | 2008-08-11 | 2010-02-25 | Olympus Corp | 脂肪吸引装置 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1996255A4 (en) | 2009-06-03 |
| WO2007103279A2 (en) | 2007-09-13 |
| EP1996255A2 (en) | 2008-12-03 |
| US20090187131A1 (en) | 2009-07-23 |
| WO2007103279A3 (en) | 2008-03-13 |
| EP1996255B1 (en) | 2013-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1996255B1 (en) | Methods and devices for retrieval of a medical agent from a physiological efferent fluid collection site | |
| US7211073B2 (en) | Methods and devices for retrieval of a medical agent from a physiological efferent fluid collection site | |
| US7300429B2 (en) | Methods and devices for retrieval of a medical agent from a physiological efferent fluid collection site | |
| US8308673B2 (en) | Methods and devices for removal of a medical agent from a physiological efferent fluid collection site | |
| JP7404310B2 (ja) | 撮像プローブおよびデリバリデバイスを含む撮像システム | |
| JP7627243B2 (ja) | イメージングシステムの動作を制御する方法及びイメージを取得するシステム | |
| JP6480521B2 (ja) | センサ送達デバイス用光ファイバセンサアセンブリ | |
| US20120065482A1 (en) | Determination of blood pump system performance and sample dilution using a property of fluid being transported | |
| JP2012505220A (ja) | インドシアニングリーンを用いたアテローム性動脈硬化の検出 | |
| CN101641045B (zh) | 用于确定微血管损伤的装置 | |
| US20110263976A1 (en) | Methods and Devices for Endovascular Introduction of an Agent | |
| US20190029637A1 (en) | A wearable sensor, and method, to monitor anti-coagulation therapy | |
| WO2025090837A1 (en) | Bodily fluid management system | |
| EP3673840A1 (en) | Apparatus for managing acute ischemic events | |
| JP7541622B2 (ja) | 腸内電位差を測定するための低侵襲装置及び方法 | |
| KR102084626B1 (ko) | 뇌혈관내 수술을 위한 광간섭성 브레인 카테터, 및 그 이용방법 | |
| EP3673841A1 (en) | Apparatus for managing acute ischemic events | |
| Forrester et al. | Angioscopy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100224 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100224 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120524 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120823 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120830 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20130318 |